Larimar Therapeutics, Inc.
NASDAQ · us_market
No AI insight generated yet for this ticker.
Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 2 OLE clinical trial for the treatment of Friedreich's ataxia, a rare, progressive and fatal disease. The company is based in Bala Cynwyd, Pennsylvania.
| Fund | Style | Shares | Value | % of Port | Change vs. last quarter | Period |
|---|---|---|---|---|---|---|
| Citadel | multi-strat | 1.05M | $4.71M | 0.01% | Trimmed-28.3% | 2026-03-31 |
| StateStreet | passive | 911.3K | $4.10M | 0.00% | Unchanged | 2026-03-31 |
| RenTech | quant | 739.9K | $3.33M | 0.01% | Added+148.9% | 2026-03-31 |
| DEShaw | quant | 575.6K | $2.59M | 0.00% | Added+31.6% | 2026-03-31 |
| TwoSigma | quant | 475.6K | $2.14M | 0.00% | Added+61.1% | 2026-03-31 |
| Wellington | fundamental | 136.5K | $614.39K | 0.00% | New | 2026-03-31 |
| FidelityFMR | fundamental | 63.6K | $286.06K | 0.00% | Added+393.6% | 2026-03-31 |
| TRowePrice | fundamental | 34.8K | $157 | 0.00% | Added+19.9% | 2026-03-31 |
| Report Date | EPS Estimate | EPS Actual | Surprise |
|---|---|---|---|
| 2026-08-13upcoming | -0.38 | — | — |
| 2026-05-14 | -0.59 | -0.31 | +47.90% |
| 2026-03-19 | -0.55 | -0.73 | -33.78% |
| 2025-11-05 | -0.42 | -0.61 | -44.20% |
| 2025-08-14 | -0.49 | -0.41 | +15.64% |
| 2025-04-30 | -0.41 | -0.46 | -12.43% |
| 2025-03-24 | -0.32 | -0.45 | -40.88% |
| 2024-10-30 | -0.37 | -0.24 | +35.20% |
| 2024-08-07 | -0.32 | -0.34 | -7.79% |
| 2024-05-09 | -0.24 | -0.27 | -12.50% |
| 2024-03-14 | -0.25 | -0.29 | -15.09% |
| 2023-11-14 | -0.23 | -0.21 | +8.42% |
| 2023-08-10 | -0.21 | -0.19 | +9.94% |
| 2023-05-15 | -0.25 | -0.15 | +39.20% |
| 2023-03-14 | -0.37 | -0.21 | +43.86% |
| 2022-11-10 | -0.42 | -0.37 | +11.90% |
| 30d | 90d | YTD | 1y | |
|---|---|---|---|---|
| LRMR | -11.68% | -36.84% | -8.66% | +54.67% |
| XLV | +2.97% | -4.64% | -3.44% | +12.69% |
| Alpha (stock − sector) | -14.64% | -32.20% | -5.22% | +41.98% |